Validated early detection metrics reduce the population requiring liver fibrosis screening

The authors aimed to evaluate and refine indicators for liver fibrosis screening to reduce the burden on healthcare resources while maintaining effective identification of at-risk individuals. By analyzing data from various cohorts, they developed a refined screening strategy that targeted only 10-22% of the population, significantly increasing the prevalence of liver fibrosis among those eligible for screening while keeping the risk low in those not eligible. This approach demonstrates a more efficient method for identifying individuals at risk of liver-related events compared to current guidelines.